These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11166584)

  • 1. Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer.
    Ranson MR; Cheeseman S; White S; Margison J
    Crit Rev Oncol Hematol; 2001 Feb; 37(2):115-20. PubMed ID: 11166584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer.
    Koukourakis MI; Koukouraki S; Giatromanolaki A; Archimandritis SC; Skarlatos J; Beroukas K; Bizakis JG; Retalis G; Karkavitsas N; Helidonis ES
    J Clin Oncol; 1999 Nov; 17(11):3512-21. PubMed ID: 10550149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caelyx/Doxil for the treatment of metastatic ovarian and breast cancer.
    Tejada-Berges T; Granai CO; Gordinier M; Gajewski W
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):143-50. PubMed ID: 12113236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal anthracyclines for breast cancer.
    Sparano JA; Winer EP
    Semin Oncol; 2001 Aug; 28(4 Suppl 12):32-40. PubMed ID: 11552228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy.
    Gabizon AA
    Cancer Invest; 2001; 19(4):424-36. PubMed ID: 11405181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer.
    Rom J; Bechstein S; Domschke C; Golatta M; Mayer C; Heil J; Thum J; Smetanay K; Windemuth-Kieselbach C; Wallwiener M; Marme F; Schuetz F; Sohn C; Schneeweiss A
    Anticancer Drugs; 2014 Feb; 25(2):219-24. PubMed ID: 24247203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes.
    Symon Z; Peyser A; Tzemach D; Lyass O; Sucher E; Shezen E; Gabizon A
    Cancer; 1999 Jul; 86(1):72-8. PubMed ID: 10391566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?
    Mamidi RN; Weng S; Stellar S; Wang C; Yu N; Huang T; Tonelli AP; Kelley MF; Angiuoli A; Fung MC
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1173-84. PubMed ID: 20661737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours.
    Koukourakis MI; Koukouraki S; Fezoulidis I; Kelekis N; Kyrias G; Archimandritis S; Karkavitsas N
    Br J Cancer; 2000 Nov; 83(10):1281-6. PubMed ID: 11044350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma.
    Lyass O; Uziely B; Ben-Yosef R; Tzemach D; Heshing NI; Lotem M; Brufman G; Gabizon A
    Cancer; 2000 Sep; 89(5):1037-47. PubMed ID: 10964334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial.
    Ranson MR; Carmichael J; O'Byrne K; Stewart S; Smith D; Howell A
    J Clin Oncol; 1997 Oct; 15(10):3185-91. PubMed ID: 9336354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas--rationale for combination with radiotherapy.
    Koukourakis MI; Koukouraki S; Giatromanolaki A; Kakolyris S; Georgoulias V; Velidaki A; Archimandritis S; Karkavitsas NN
    Acta Oncol; 2000; 39(2):207-11. PubMed ID: 10859012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal doxorubicin in conjunction with reirradiation and local hyperthermia treatment in recurrent breast cancer: a phase I/II trial.
    Kouloulias VE; Dardoufas CE; Kouvaris JR; Gennatas CS; Polyzos AK; Gogas HJ; Sandilos PH; Uzunoglu NK; Malas EG; Vlahos LJ
    Clin Cancer Res; 2002 Feb; 8(2):374-82. PubMed ID: 11839652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of liposomal anthracyclines in breast cancer.
    Lorusso V; Manzione L; Silvestris N
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi70-3. PubMed ID: 17591837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From conventional to stealth liposomes: a new frontier in cancer chemotherapy.
    Cattel L; Ceruti M; Dosio F
    Tumori; 2003; 89(3):237-49. PubMed ID: 12908776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected low efficacy of stealth liposomal doxorubicin (Caelyx) and vinorelbine in metastatic breast cancer.
    Rimassa L; Carnaghi C; Garassino I; Salvini P; Ginanni V; Gullo G; Morenghi E; Santoro A
    Breast Cancer Res Treat; 2003 Jan; 77(2):185-8. PubMed ID: 12602917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (99m)Tc-labelled Stealth liposomal doxorubicin (Caelyx) in glioblastomas and metastatic brain tumours.
    Laverman P; Boerman OC; Storm G; Oyen WJ
    Br J Cancer; 2002 Feb; 86(4):659-61. PubMed ID: 11870553
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles.
    Waterhouse DN; Tardi PG; Mayer LD; Bally MB
    Drug Saf; 2001; 24(12):903-20. PubMed ID: 11735647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group.
    Judson I; Radford JA; Harris M; Blay JY; van Hoesel Q; le Cesne A; van Oosterom AT; Clemons MJ; Kamby C; Hermans C; Whittaker J; Donato di Paola E; Verweij J; Nielsen S
    Eur J Cancer; 2001 May; 37(7):870-7. PubMed ID: 11313175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal anthracyclines in metastatic breast cancer: clinical update.
    Rivera E
    Oncologist; 2003; 8 Suppl 2():3-9. PubMed ID: 13679590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.